Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)
Clinical trial NCT07047716 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07047716
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-22
- Primary completion
- 2028-09-01
- Enrollment
- 339
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.